Transfusion support in COVID‐19 patients: Impact on hospital blood component supply during the outbreak
Pandemic
Blood product
Blood component
DOI:
10.1111/trf.16171
Publication Date:
2020-11-04T17:41:41Z
AUTHORS (10)
ABSTRACT
Abstract Background During the COVID‐19 outbreak, most hospitals deferred elective surgical procedures to allow space for overwhelming number of patient admissions, expecting a decrease in routine blood component requirements. However, because transfusion support needs patients are not well known, its impact on hospital supply is uncertain. The objective this study was assess effect pandemic demand. Study Design and Methods Transfusion records during peak (March 1‐April 30, 2020) were reviewed our center changes Results period 636 received total 2934 components, which reflects 17.6% reduction requirements with regard same 2019, donations Madrid dropped by 45%. demand decreased significantly outbreak (50.2%). Blood usage hematology oncology departments remained unchanged, while day ward halved, intensive care unit increased 116%. A 6.2% all COVID inpatients required support. consumed 19% counterbalanced savings owed procedures. Conclusion Although only minority transfusion, expected caused lack partially offset large admitted pandemic. This fact must be taken into account when planning supply.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (15)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....